药物经济学评价指南研究与应用的进展

The progress of research and application on pharmacoeconomic guidelines

药物经济学评价指南是一些政府为了控制快速增长的药费和在有限的卫生预算下分配资源的有效途径。作者通过比较欧洲四国经济学指南的制订背景和异同点 ,认为药物经济学评价指南的制订必须与各国国情、卫生保健体系和政策目标相适应 ,药物经济学指南亟待完善和发展。

Pharmacoeconomic guidelines come as a response by some governments to solve problem of rising pharmaceutical expenditure and could be seen as an approach to contain costs and improve resource allocation under a restricted health resource. By a comparative study on background, similarities and differences among four countries' guidelines for pharmacoeconomic evaluation in Europe, we figure that the making of pharmacoeconomic evaluation guideline should meet the needs of country backround, health care system and policy targets. Guidelines need revising and developing.